HVEM(14-39) is a peptide inhibitor of the B and T lymphocyte attenuator (BTLA). It binds to BTLA with a dissociation constant (KD) of 0.102 µM. By modulating BTLA and HVEM expression in T cells, HVEM(14-39) enhances activation and proliferation of T cells and promotes their transition to effector memory T cells. Additionally, HVEM(14-39) can inhibit tumor cell proliferation and induce late apoptosis (apoptosis). This compound has immunomodulatory effects, making it useful for tumor research.
Molecular Weight:
2781.13
Formula:
C115H182N32O40S4
Target:
Apoptosis
* VAT and and shipping costs not included. Errors and price changes excepted
